선별등재 제도에 대한 전문가와 제약회사의 인식도 비교분석

• 영문명: A comparative Analysis of Perception of Health Professionals and Pharmaceutical Companies on the Positive List System
• 발행기관: 대한약학회
• 저자명: 하동문(Dong Mun Ha) 이수경(Su Kyoung Lee) 김대업(Dae Up Kim) 정규혁(Kyu Hyuck Chung) 이의경(Eui Kyung Lee)
• 간행물 정보: 『약학회지』제54권 제4호 (2010년), 309~315쪽, 전체 7쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2010.08.31

영문 초록

The Positive List System was newly introduced in South Korea as of January 2007. This study aims to survey and compare perception of and attitudes toward the Positive List System in the process of new drug listing that health professionals and pharmaceutical companies have. 50 professionals and 52 companies answered the questionnaire regarding health policy environments, policy decision/enforcement process, policy effects and satisfaction related to introducing the Positive List System. SAS 9.1 was used for statistical analyses. The results showed that participants had the general sympathy with health policy environments for the introduction of the Positive List System into South Korea. However, the response rates of policy decision/enforcement process and effects were negative and these tendencies were more striking in pharmaceutical companies. As for policy satisfaction, participants marked positive responses more than negative ones. It is necessary to remedy and supplement problems with policy decision/enforcement policy and effects revealed in this study and to improve the Positive List System through gathering opinions among groups and organization concerned.

키워드

positive list system new drug drug listing